Long‐term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

enthalten in: Hepatology | 2013

von Hosaka, T. | Suzuki, F. | Kobayashi, M. | +10

Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C

enthalten in: Hepatology | 2013

von Arase, Y. | Kobayashi, M. | Suzuki, F. | +10

Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C

enthalten in: Hepatology | 2013

von Arase, Y. | Kobayashi, M. | Suzuki, F. | +10

Complicated relationships of amino acid substitution in hepatitis C virus core region and IL28B genotype influencing hepatocarcinogenesis

enthalten in: Hepatology | 2012

von Akuta, N. | Suzuki, F. | Seko, Y. | +11

Influence of ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevir

enthalten in: Hepatology | 2011

von Suzuki, F. | Suzuki, Y. | Akuta, N. | +14

Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin Potential conflict of interest: Nothing to report.

enthalten in: Hepatology | 2010

von Akuta, N. | Suzuki, F. | Hirakawa, M. | +13

Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis CPotential conflict of interest: Nothing to report.

enthalten in: Hepatology | 2009

von Arase, Y. | Suzuki, F. | Suzuki, Y. | +9

Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesisFNR HREF="fn1">FN ID="fn1">Potential conflict of interest: Nothing to report.

enthalten in: Hepatology | 2007

von Akuta, N. | Suzuki, F. | Kawamura, Y. | +9